LMB vs ULCC

LMB exhibits strong financial health with a Piotroski F-Score of 7/9 and a conservative Debt/Equity ratio of 0.29. While the current price of $82.59 is significantly above the Graham Number ($34.97), it trades below the growth-based intrinsic value of $95.28 and well below the analyst target of $116.60. The company demonstrates exceptional growth momentum with 30.1% YoY revenue growth and a remarkable 25-quarter track record of earnings surprises. Despite bearish insider selling and a weak technical trend, the fundamental trajectory and profitability metrics support a bullish outlook.

ULCC exhibits critical financial instability, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental improvement across all health metrics. The company is severely over-leveraged with a Debt/Equity ratio of 11.13 and faces a liquidity crisis with a Current Ratio of 0.46. While the stock has seen a 1-year price recovery of 38.2%, this appears to be speculative as the company maintains negative operating margins and stagnant revenue growth. The combination of extreme debt and zero fundamental health scores suggests a high risk of insolvency.